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Aims of Talk
• Overview of methodology for 
• Two stage meta-analysis of multi-study joint longitudinal and time-to-event data
• One stage meta-analysis of multi-study joint longitudinal and time-to-event data
• Review of current reporting of single study joint models applied to medical datasets
• Introduction of software package in R to implement methods
Joint longitudinal and time-to-event data (single study)
• Methods to simultaneously model potentially related longitudinal and time-to-event data
• Can produce less biased more efficient results than standalone cases where linked 
longitudinal and time-to-event data exists
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Meta-Analysis (MA)
• Systematic pooling of results from multiple studies
• Allows increased precision, identification of effect sizes too small to be identified in 
single studies, and allows questions additional to those originally posed in the data 
to be answered
• Gold standard – Individual Participant/Patient Data (IPD) meta-analyses, where 
data for each individual recorded in studies identified in the meta-analysis is 
available.
Joint longitudinal and time-to-event data (multi-study)
• Data available from multiple studies
• Clustering of data within studies must be accounted for (e.g. through random effects, 
interaction terms, stratified baseline hazard)
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Time-to-event Sub-model
𝜆𝑘𝑖 𝑡 = ℎ 𝑊2, 𝛼
𝜆𝑘𝑖 𝑡 = 𝜆0 𝑡 exp 𝑋2𝛽2 +𝑊2
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Approaches to modelling multi-study IPD joint data
• Two main approaches – one stage or two stage
• Two stage approaches
• Separate joint models fitted to data from each study
• Results from each study pooled using standard meta-analytic techniques
• One stage approaches
• Joint model fitted to meta-dataset (containing data from all studies)
• Clustering of data must be accounted for
Real Data – subset of the INDANA dataset
• IPD from multiple studies investigating the effect of no treatment versus any treatment 
for hypertensive patients
• Longitudinal data measured at baseline, 6 months, then annually thereafter to maximum 
of 7 years.  Measurement patterns varied between studies
• Using subset with data for longitudinal outcome systolic blood pressure (SBP) and time to 
death, data available from 6 studies. Proportions of individuals from each study, and 
proportions events/censored within each study kept same as full dataset.  Full analysis 
using entire dataset currently running.
• Evidence of a changepoint in the data at 6 month, so exp −3 ∗ 𝑡𝑖𝑚𝑒 term included in 
the model

Two stage methods
Two stage methods - overview
Stage 1: Joint model fitted to data from each study
Stage 2: Study specific parameters pooled using standard meta-analytic techniques
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• Inverse variance method used (DerSimonian method used for random meta-analyses)
• Both fixed and random effects meta-analyses fitted and compared
• Separate meta-analyses for each parameter of interest
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Two stage methods - recommendations
Preliminary work
• For each study:
• Plot longitudinal trajectories separately for 
those experiencing an event and those 
censored.
• Produce Kaplan-Meier plots for e.g. each 
treatment group
• Use plots to assess whether an association 
between longitudinal and time-to-event outcomes 
is feasible
• Use plots and clinical background of the data to 
select:
• Longitudinal sub-model
• Time-to-event sub-model
• Association structure
Two stage methods - recommendations
First Stage 
• Group studies such that chosen model 
structure within each group is 
identical.
• Within each group, fit identical joint 
models to data from each study.  
Model structures can differ between 
groups.
Study 1
Study 2
Study 3
Study 6
Study 4
Study 5
Study 7
Group 1
Group 2
Group 1
Group 2
Group 2
Group 1
Group 1
Fit model 1
Fit model 2
Fit model 1
Fit model 2
Fit model 2
Fit model 1
Fit model 1
Two stage methods - recommendations
Second Stage
• For each study extract model 
parameters, precision estimates and 
sample size
• Pool estimates within groups using 
standard MA techniques. 
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Current reporting standard of 
joint models 
Review of standard of published joint data analyses
Review of standard of published joint data analyses
Longitudinal 
MA
Time-to-event MA
Association 
MA
Coefficients reported (%) 45 (69.2) 46 (70.8) 51 (78.5)
Precision reported (%) 44 (67.7) 45 (69.2) 50 (76.9)
Standard Errors reported (%) 22 (33.8) 23 (35.4) 25 (38.5)
Confidence Intervals (CI) reported (%) 30 (46.2) 32 (49.2) 36 (55.4)
Significance level reported (%) 57 (87.7)
Sample size reported (%) 64 (98.5)
MA possible given reported information (%)
All identified studies (N=65) 44 (67.7) 45 (69.2) 50 (76.9)
Studies using joint models to account for dropout 
(N=22)
18 (81.8) 14 (63.6) 15 (68.2)
Studies using joint models to include time varying 
covariate in time-to-event sub-model (N=4)
2 (50.0) 3 (75.0) 3 (75.0)
One stage methods
One stage methods - overview
• Longitudinal sub-model: linear mixed effects model with zero mean random effects. 
• Time-to-event sub-model: Proportional hazards model with unspecified baseline hazard
• Association structure: random effects proportional association structure
• Aim was not to assess affect of range of covariates, only to assess the different model groups
Group Method to account for between study heterogeneity
0 Between study heterogeneity ignored
1 Fixed interaction term between treatment and study in each sub-model
2 Fixed study indicator in longitudinal sub-model, study level random treatment effect
3 Study level random intercept and random treatment effect
4
Fixed interaction term between treatment and study in longitudinal sub-model, baseline hazard 
stratified by study
5
Fixed study indicator in longitudinal sub-model, study level random treatment effect, baseline 
hazard stratified by study
One stage methods – real data
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One stage methods – simulation work
• Ongoing
• Scenarios designed to investigate behaviour of different model groups under e.g.
• Varying association levels
• Low (~25%) or high (~75%) event rate
• Varying numbers of included studies
Software – joineRmeta package
• Currently available from GitHub -
https://github.com/mesudell/joineRmeta/
• Functions to:
• Easily plot multi-study joint data
• To automatically extract and meta-analyse specified model 
parameters from supplied joint model fits
• Model three level joint data allowing for
• Random effects only association structure
• Individual level and study level random effects
• Un-stratified or stratified baseline hazard
• Simulation of multi-study joint data
Discussion
• One stage methods
• Use of study level random effects may be unwise unless number of studies is over a 
certain threshold
• Interaction terms between covariates and study membership would quickly become 
cumbersome with large numbers of studies
• Allows in depth investigation of between study heterogeneity
• Two stage methods
• Faster than one stage methods
• Increasing difference between coefficient estimates in separate time-to-event 
models compared to joint models as association increases in magnitude 
• Multivariate meta-analysis of results rather than separate meta-analyses of each 
coefficient might be beneficial – future research
• Time commitment to bootstrap models is a concern
Conclusions
• Care must be taken during two stage meta-analyses of joint data to pool only 
parameters with comparable interpretations
• Current reporting of joint models may hamper an aggregate data meta-analysis of 
joint data given current reporting standards
• A variety of methods exist to model multi-study joint data in a one stage analyses, 
however some may not be appropriate unless the number of studies in the meta-
analysis is over a given threshold
Thank you for listening.
Any questions?
